We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SONN market cap is 5.38M. The company's latest EPS is USD -2.4729 and P/E is -0.75.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 37k | 19k | 0 | 0 | 0 |
| Operating Income | -3.6M | -1.28M | -3.87M | -3.53M | -3.17M |
| Net Income | -3.68M | -1.17M | 366k | -3.51M | -3.13M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 484k | 350k | 148k | 19k |
| Operating Income | -24.24M | -25.09M | -29.67M | -18.79M | -11.85M |
| Net Income | -65.6M | -24.98M | -29.72M | -18.83M | -7.44M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.43M | 5.34M | 5.91M | 5.8M | 2.77M |
| Total Liabilities | 5.66M | 2.77M | 2.86M | 3.18M | 3.26M |
| Total Equity | -226k | 2.57M | 3.05M | 2.62M | -486k |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.99M | 28.99M | 5.83M | 5.43M | 2.77M |
| Total Liabilities | 4.97M | 6.73M | 8.37M | 5.66M | 3.26M |
| Total Equity | 3.02M | 22.26M | -2.54M | -226k | -486k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.34M | -3.09M | -2.37M | -5.44M | -8.61M |
| Investing | -443k | N/A | N/A | -12k | -12k |
| Financing | 21.01M | 3.84M | 3.88M | 6.73M | 6.5M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.62M | -22.55M | -27.69M | -21.34M | -8.61M |
| Investing | -76k | -4k | -896k | -443k | -12k |
| Financing | 23.01M | 42.83M | 4.01M | 21.01M | 6.5M |
| Market Cap | 5.38M |
| Price to Earnings Ratio | -0.75 |
| Price to Sales Ratio | 293.65 |
| Price to Cash Ratio | 37.37 |
| Price to Book Ratio | -11.45 |
| Dividend Yield | - |
| Shares Outstanding | 3.01M |
| Average Volume (1 week) | 524.65k |
| Average Volume (1 Month) | 332.65k |
| 52 Week Change | -83.55% |
| 52 Week High | 18.7192 |
| 52 Week Low | 1.41 |
| Spread (Intraday) | 0.01 (0.56%) |
| Company Name | Sonnet BioTherapeutics Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sonnetbio.com |
| Industry | management consulting svcs (8742) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
